Literature DB >> 25318869

Alterations in cardiac structure and function in a modified rat model of myocardial hypertrophy.

Wen-Jun Dai1,2, Qi Dong3, Min-Sheng Chen4, Lu-Ning Zhao5, Ai-Lan Chen6, Zhen-Ci Li7, Shi-Ming Liu2.   

Abstract

This study was aimed to establish a stable animal model of left ventricular hypertrophy (LVH) to provide theoretical and experimental basis for understanding the development of LVH. The abdominal aorta of male Wistar rats (80-100 g) was constricted to a diameter of 0.55 mm between the branches of the celiac and anterior mesenteric arteries. Echocardiography using a linear phased array probe was performed as well as pathological examination and plasma B-type natriuretic peptide (BNP) measurement at 3, 4 and 6 weeks after abdominal aortic constriction (AAC). The results showed that the acute mortality rate (within 24 h) of this modified rat model was 8%. Animals who underwent AAC demonstrated significantly increased interventricular septal (IVS), LV posterior wall (LVPWd), LV mass index (LVMI), cross-sectional area (CSA) of myocytes, and perivascular fibrosis; the ejection fraction (EF), fractional shortening (FS), and cardiac output (CO) were consistently lower at each time point after AAC. Notably, differences in these parameters between AAC group and sham group were significant by 3 weeks and reached peaks at 4th week. Following AAC, the plasma BNP was gradually elevated compared with the sham group at 3rd and 6th week. It was concluded that this modified AAC model can develop LVH, both stably and safely, by week four post-surgery; echocardiography is able to assess changes in chamber dimensions and systolic properties accurately in rats with LVH.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25318869     DOI: 10.1007/s11596-014-1328-7

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  21 in total

1.  The opposing effects of CCN2 and CCN5 on the development of cardiac hypertrophy and fibrosis.

Authors:  Pyoung Oh Yoon; Min-Ah Lee; Hyeseon Cha; Moon Hee Jeong; Jooyeon Kim; Seung Pil Jang; Bo Youn Choi; Dongtak Jeong; Dong Kwon Yang; Roger J Hajjar; Woo Jin Park
Journal:  J Mol Cell Cardiol       Date:  2010-04-27       Impact factor: 5.000

2.  Regulation of fibrillar collagen gene expression and protein accumulation in volume-overloaded cardiac hypertrophy.

Authors:  T Namba; H Tsutsui; H Tagawa; M Takahashi; K Saito; T Kozai; M Usui; K Imanaka-Yoshida; T Imaizumi; A Takeshita
Journal:  Circulation       Date:  1997-05-20       Impact factor: 29.690

3.  Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements.

Authors:  D J Sahn; A DeMaria; J Kisslo; A Weyman
Journal:  Circulation       Date:  1978-12       Impact factor: 29.690

4.  Structural, functional, and molecular characterization of the SHHF model of heart failure.

Authors:  Jonathan R R Heyen; Eileen R Blasi; Kristen Nikula; Ricardo Rocha; Heather A Daust; Gregory Frierdich; John F Van Vleet; Pam De Ciechi; Ellen G McMahon; Amy E Rudolph
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-11       Impact factor: 4.733

5.  A comparative serial echocardiographic analysis of cardiac structure and function in rats subjected to pressure or volume overload.

Authors:  Elliott J F Cantor; Andrea P Babick; Zainisha Vasanji; Naranjan S Dhalla; Thomas Netticadan
Journal:  J Mol Cell Cardiol       Date:  2005-05       Impact factor: 5.000

6.  Improvement of cardiac function by a cardiac Myosin activator in conscious dogs with systolic heart failure.

Authors:  You-Tang Shen; Fady I Malik; Xin Zhao; Christophe Depre; Sunil K Dhar; Patricio Abarzúa; David J Morgans; Stephen F Vatner
Journal:  Circ Heart Fail       Date:  2010-05-24       Impact factor: 8.790

7.  Concentric left ventricular remodeling in endothelial nitric oxide synthase knockout mice by chronic pressure overload.

Authors:  Hartmut Ruetten; Stefanie Dimmeler; Doris Gehring; Christian Ihling; Andreas M Zeiher
Journal:  Cardiovasc Res       Date:  2005-02-24       Impact factor: 10.787

8.  Heart failure after long-term supravalvular aortic constriction in rats.

Authors:  Marvin O Boluyt; Kathleen G Robinson; Andrea L Meredith; Subha Sen; Edward G Lakatta; Michael T Crow; Wesley W Brooks; Chester H Conrad; Oscar H L Bing
Journal:  Am J Hypertens       Date:  2005-02       Impact factor: 2.689

9.  B-type natriuretic peptide receptors in hypertrophied adult rat cardiomyocytes.

Authors:  L Nader; L Lahoud; E Chouery; G Aftimos; P Bois; N A Farès
Journal:  Ann Cardiol Angeiol (Paris)       Date:  2009-10-17

10.  Physical overdistension converts ventricular cardiomyocytes to acquire endocrine property and regulate ventricular atrial natriuretic peptide production.

Authors:  J Gu; M D'Andrea; M Seethapathy; C McDonnell; R Cichon
Journal:  Angiology       Date:  1991-03       Impact factor: 3.619

View more
  3 in total

1.  Celecoxib prevents pressure overload-induced cardiac hypertrophy and dysfunction by inhibiting inflammation, apoptosis and oxidative stress.

Authors:  Chi Zhang; Fan Wang; Yingxia Zhang; Yimin Kang; Haisheng Wang; Mingming Si; Liping Su; Xue Xin; Feng Xue; Fei Hao; Lechu Yu; Jinzhong Xu; Yanlong Liu; Mingming Xue
Journal:  J Cell Mol Med       Date:  2015-10-29       Impact factor: 5.310

2.  Trimetazidine attenuates pressure overload-induced early cardiac energy dysfunction via regulation of neuropeptide Y system in a rat model of abdominal aortic constriction.

Authors:  Ailan Chen; Wanglin Li; Xinyu Chen; Yuechun Shen; Wenjun Dai; Qi Dong; Xinchun Li; Caiwen Ou; Minsheng Chen
Journal:  BMC Cardiovasc Disord       Date:  2016-11-17       Impact factor: 2.298

3.  Rutaecarpine Ameliorates Pressure Overload Cardiac Hypertrophy by Suppression of Calcineurin and Angiotensin II.

Authors:  Shujun Li; Bo Huang; Changfei Zhou; Jingshan Shi; Qin Wu; Qingsong Jiang
Journal:  Evid Based Complement Alternat Med       Date:  2021-01-12       Impact factor: 2.629

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.